Millendo Therapeutics, Inc. is a biopharmaceutical company. The company is engaged in the development of novel treatments for endocrine diseases. Its products include livoletide and nevanimibe. The company was founded in April, 2011 and is headquartered in Ann Arbor, MI.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
34
Frequently Asked Questions
What is Market Cap of Millendo Therapeutics Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Millendo Therapeutics Inc market cap is $148.81M.
What is the 52-week high for Millendo Therapeutics Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Millendo Therapeutics Inc 52 week high is $17.34 as of September 15, 2025.
What is the 52-week low for Millendo Therapeutics Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Millendo Therapeutics Inc 52 week low is $6.77 as of September 15, 2025.
What is Millendo Therapeutics Inc stock price today?
Millendo Therapeutics Inc stock price today is $11.60.
What was Millendo Therapeutics Inc stock price yesterday?
Millendo Therapeutics Inc stock price yesterday was $11.14.
What is the PE ratio of Millendo Therapeutics Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Millendo Therapeutics Inc’s P/E ratio is None.
What is the Price-to-Book ratio of Millendo Therapeutics Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Millendo Therapeutics Inc P/B ratio is 2.4191.
What is Millendo Therapeutics Inc's EBITDA?
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Millendo Therapeutics Inc's EBITDA is -5.45.
What is the 50-day moving average of Millendo Therapeutics Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Millendo Therapeutics Inc 50-day moving average is $14.94.
How many employess does Millendo Therapeutics Inc has?